Germany Focuses on Private Sector Treatment Access Demand for obesity GLP-1 treatment in Germany is projected to grow at a CAGR of 19.6%, constrained by statutory health insurance exclusions for anti-obesity medications that limit public reimbursement
Complex Carbohydrates Complex carbohydrates contain minerals, vitamins, and fiber that benefit your overall health
Simon Medicaid GLP-1 Coverage and Prescribing Patterns Studying how state Medicaid coverage of GLP-1s for weight management affects prescribing and spending, using staggered adoption across states, from Coady Wing, Wei-Lun Lo, Maddie Potter, Tarik Yuce, Alberto Ortega, John Cawley, Thuy D
Recently, Eli Lilly reported they anticipate submitting Orforglipron for FDA approval in the second half of 2025, with potential availability shortly after if approved
The Build & Define protocol can be part of a broader approach depending on your goals
Often, they reflect expected medication effects or transient physiological changes